Search Login Register

prasugrel Summary

Description: a P2Y(12) receptor antagonist with antiplatelet activity; structure in first source

Also Known As: CS 747; CS-747; LY 640315; LY-640315; LY640315

Networked: 640 relevant articles (110 outcomes, 209 trials/studies) for this Bio-Agent

Key Diseases for which prasugrel is Relevant

  1. Myocardial Infarction : 50 outcomes 77 studies in 155 results
  2. Hemorrhage : 49 outcomes 54 studies in 262 results
  3. Acute Coronary Syndrome : 41 outcomes 85 studies in 274 results
  4. Stroke (Strokes) : 10 outcomes 14 studies in 84 results
  5. Thrombosis (Thrombus) : 8 outcomes 13 studies in 82 results
Show All >>

Drugs Related to prasugrel

  1. clopidogrel (Plavix)
  2. Ticagrelor
  3. Aspirin (Acetylsalicylic Acid)
  4. thienopyridine
  5. Platelet Aggregation Inhibitors (Antiplatelet Drugs)
  6. Thienopyridines
  7. bivalirudin (Angiomax)
  8. Glycoproteins (Glycoprotein)
  9. Ticlopidine (Ticlid)
  10. cangrelor
Show All >>

Therapies Related to prasugrel

  1. Stents
  2. Coronary Artery Bypass (Coronary Artery Bypass Surgery)
  3. Transplants (Transplant)
  4. Platelet Transfusion (Blood Platelet Transfusions)
  5. Angioplasty (Angioplasty, Transluminal)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.